Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFutura Medical Regulatory News (FUM)

Share Price Information for Futura Medical (FUM)

Share Price is delayed by 15 minutes
Get Live Data
0.576    0.074 (14.74%)
Bid:
0.502
Ask:
0.668
Spread: 0.166 (33.068%)
Market Cap: £3.35m
FUM Live PriceLast checked at - London Stock Exchange

Intraday Futura Medical Share Chart

Board Appointment

24 Sep 2008 07:00

RNS Number : 1282E
Futura Medical PLC
24 September 2008
Β 

ο»Ώ

For immediate releaseΒ 

24Β September 2008

Futura Medical plc

("Futura" or "the Group" or "the Company")

Appointment of Finance Director

Futura Medical plc (AIM: FUM), the pharmaceutical group that develops innovative products for consumer healthcare, is pleased to announce thatΒ Derek Martin, who joined Futura as Financial Controller inΒ April 2007, has been appointedΒ to the Board of Futura asΒ Finance Director with immediate effect.Β 

Derek Adrian Martin, age 47, is a chartered accountant with a breadth of experience gained across a number of sectors, including technology and retail,Β atΒ private and publicly quotedΒ companies of varying sizes.

Prior to joining Futura, Mr Martin was a financial controller at Thales.Β Β Between 2005 and 2007 he was financial controller at Links of LondonΒ Limited, the jewellery chain, beforeΒ its disposal to Folli Follie,Β and between 2001 and 2005 he was financial controller at Entuity Limited, aΒ USΒ software company. Mr Martin gained AIM experience in the role of financial controllerΒ at World Telecom plc, between 1996 and 2001,Β prior to the company's saleΒ to Torc TelecomΒ Limited.

James Barder, Futura's Chief Executive, said:Β "I am delighted to welcome Derek to the role of Finance Director and to Futura's Board. He has worked at Futura in the role of Financial Controller sinceΒ April 2007Β and has proved himself to be a highly competent financeΒ executive.Β I look forward to his contribution to Futura's Board."

There are no further disclosures to be made in accordance with Schedule 2 (g) of the AIM rules.

For any further information please contact:

Futura Medical plc

James Barder, Chief Executive

Tel: +44 (0) 1483 685 670

mail to:Β james.barder@futuramedical.co.uk

www.futuramedical.co.ukΒ 

Canaccord Adams

Ryan Gaffney / Adria Da BreoΒ Richards

Tel: +44 (0) 20 7050 6500Β 

For media enquiries please contact:Β 

Buchanan Communications

Mark CourtΒ / Rebecca Skye Dietrich

Tel: +44 (0) 20 7466 5000

Β 

Β Β 

Notes to Editors

Futura Medical plc

Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.

Futura is based in Guildford,Β Surrey, and its shares trade on the AIM market of the London Stock Exchange.

www.futuramedical.co.uk

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
BOAQXLFLVKBBBBF
Date   Source Headline
6th Feb 200611:34 amRNSAdditional Listing
1st Feb 20067:00 amRNSAdditional Listing
3rd Jan 200612:50 pmRNSHolding(s) in Company
21st Dec 20054:14 pmRNSAdditional Listing
9th Dec 20057:01 amRNSRe: Global Rights
30th Nov 200510:18 amRNSAdditional Listing
28th Nov 20057:01 amRNSEU Marketing Submission
21st Nov 20057:02 amRNSStudy Results
7th Nov 20057:00 amRNSStudy Results
5th Sep 20057:00 amRNSInterim Results
12th Aug 20057:00 amRNSProduct development update
19th Jul 200511:00 amRNSNotice of Results
6th Jul 20057:00 amRNSSSL acquires rights to FLD500
5th Jul 200510:45 amRNSHolding(s) in Company
6th Jun 20053:38 pmRNSNotice of AGM
17th May 20052:44 pmRNSHolding(s) in Company
25th Apr 20057:00 amRNSManufacturing trials
22nd Mar 200510:11 amRNSGrant of options
21st Mar 20057:01 amRNSFinal Results
18th Mar 200512:58 pmRNSNotice of Results
28th Feb 20051:06 pmRNSChange of Advisers
1st Feb 20054:00 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.